Related Experiment Videos
Prognostic factors in breast carcinoma
1Department of Pathology, University of California, San Francisco, USA.
Current Opinion in Obstetrics & Gynecology
|February 1, 1995
Summary
Accurate assessment of breast carcinoma recurrence risk is crucial. Identifying node-negative patients who will develop recurrent tumors guides adjuvant therapy decisions, improving outcomes.
Area of Science:
- Oncology
- Pathology
Background:
- Mammography advancements lead to earlier breast carcinoma detection.
- A significant percentage of node-negative breast carcinoma patients experience tumor recurrence and mortality.
- Accurate risk stratification is essential for guiding adjuvant therapy in node-negative breast carcinoma.
Purpose of the Study:
- To review recent findings on identifying subsets of node-negative breast carcinoma patients at variable risk for recurrent disease.
- To provide therapeutic information for optimizing treatment strategies.
Main Methods:
- Review of recent scientific literature and reports.
- Analysis of risk factors associated with breast carcinoma recurrence in node-negative patients.
Main Results:
- Early detection through mammography identifies more node-negative breast carcinomas.
- 20-30% of node-negative patients face recurrence and mortality risks.
- 70-80% of node-negative patients appear cured by surgery alone.
Conclusions:
- Accurate assessment of recurrence risk factors is vital for node-negative breast carcinoma patients.
- Identifying high-risk subsets allows for consideration of adjuvant therapies.
- This aids in tailoring treatment and improving survival rates for breast carcinoma patients.